First case of mother-to-infant HIV type 1 group O transmission and evolution of C2V3 sequences in the infected child

AIDS Research and Human Retroviruses

Volumn 14, Issue 1, 1998, Pages 15-23

  Chaix Baudier, Marie Laure ^a   Chappey, Colombe ^b   Burgard, Marianne ^a   Letourneur, Franck ^c   Igual, Janine ^d   Saragosti, Sentob ^c   Rouzioux, Christine ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c INSTITUT COCHIN   (France)

^d Hopital Laennec   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; ENVELOPE GENE; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEROTYPE; VERTICAL TRANSMISSION; VIRUS ENVELOPE; VIRUS ISOLATION; VIRUS TRANSMISSION; VIRUS TYPING;

EID: 0031984622     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1998.14.15     Document Type: Article

References (50)

1. Ganeshan S, Dickover RE, Korber BTM, Bryson YJ, and Wolinsky SM: Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J Virol 1997;71:663-677.
2. Chameau P, Borman AM, Quillent C, Guétard D, Chamaret S, Cohen J, Rémy G, Montagnier L, and Clavel F: Isolation and envelope sequence of a highly divergent HIV-1 isolate: Definition of a new HIV-1 group. Virology 1994;205:247-253.
3. Myers G, Korber B, Foley B, Jeang KT, Mellors JW, and Wain-Hobson S: Human Retroviruses and AIDS. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, New Mexico, 1996.
4. Louwagie J, Janssens W, Mascola LJ, Heyndrickx L, Hegerich P, van der Groen G, McCutchan FE, and Burke DS: Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol 1995;69:263-271.
5. Louwagie J, McCutchan FE, Peeters M, Brennan TP, Scanders-Buell E, Eddy GA, van der Groen G, Fransen K, Gershy-Damet GM, Deleys R, and Burke DS: Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS 1993;7:769-780.
6. Leitner T and Albert J. A new genetic subtype of HIV-1. In: Human Retroviruses and AIDS: A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences (Myers G, Korber BTM, and Hahn BH, eds.), Vol. III. Los Alamos National Laboratory, Los Alamos, New Mexico, 1995, pp. 147-150.
7. Kostrikis LG, Bagdades E, Cao Y, Zhang L, Dimitriou D, and Ho DD: Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: Identification of a new subtype designated subtype I. J Virol 1995;69:6122-6130.
8. Janssens W, Heyndrickx L, Fransen K, Motte J, Peeters M, Nkengasong JN, Ndumbe PM, Delaporte E, Perret JL, Attende C, Piot P, and van der Groen G: Genetic and phylogenetic analysis of env subtypes G and H in central Africa. AIDS Res Hum Retroviruses 1994;10:877-879.
9. Dumitrescu O, Kalish ML, Kliks SC, Bandea CI, and Levy JA: Characterisation of human immunodeficiency virus type 1 isolates from children in Romania: Identification of a new envelope subtype. J Infect Dis 1994;169:281-288.
10. McCutchan FE, Salminen MO, Carr JK, and Burke DS: HIV-1 genetic diversity. AIDS 1996;10:S13-S20.
11. Gürtler LG, Hauser PH, Eberle J, von Brunn A, Knapp S, Zenkeng L, Tsague JM, and Kaptue L: A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994;68:1581-1585.
12. Loussert-Ajaka I, Choix ML, Korber B, Letourneur F, Gomas E, Allen E, Ly TD, Brun-Vézinet F, Simont F, and Saragostin S: Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol 1995;69:5640-5649.
13. Vanden Haesevelde M, Decourt JL, De Leys RJ, Vanderborght B, van der Groen G, van Heuverswijn H, and Saman E: Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate. J Virol 1994;68: 1586-1596.
14. Zekeng L, Gurtler L, Afane Z, Sam_Abbenyi A, Mbouni-Essomba G, Mpoudi-Ngolle E, Lobe-Monny M, Tapko JB, and Kaptue L: Prevalence of HIV-1 subtype O infection in Cameroon: Preliminary results. AIDS 1994;8:1626-1628.
15. Hunt JC, Golden AM, and Vallari A: Molecular and serologic characterization of four HIV-1 group O from Equatorial Guinea. AIDS Res Hum Retroviruses 1995;11:S144.
16. Heyndrickx L, Alary M, Janssens W, Davo N, and van der Groen G: HIV-1 group O and group M dual infection in Benin. Lancet 1996;347:902-903.
17. Peeters M, Gueye A, M'Boup S, Bibollet-Ruche F, Ekaza E, Mulanga C, Rasmata O, Gandji R, Mpele P, Dibanga G, Koumare B, Saidou M, Esu-Williams E, Lombart JP, Badombena W, Luo N, Van den Haesevelde M, and Delaporte E: Geographic distribution of HIV-1 O viruses in Africa. AIDS 1997;11:493-498.
18. Songok EM, Libondo DK, Rotich MC, Oogo SA, and Tukei PM: Surveillance for HIV-1 subtypes O and M in Kenya. Lancet 1996;347:1700.
19. Jonassen T, Stene-Johansen K, Berg ES, Hungnes O, Lindboe CF, Froland SS, and Grinde B: Sequence analysis of HIV-1 group O from Norwegian patients infected in 1960s. Virology 1997;231: 43-47.
20. The Working Group on Mother-to-Child Transmission of HIV: Rates of mother-to-child transmission of HIV-1 in Africa, America, and Europe: Results from 13 perinatal studies. J AIDS 1995;8:506-510.
21. Lepage P, Vande Perre P, Carael M, Nsengumuremyi F, Nkurunziza J, Butzler JP, and Sprecher S: Postantal transmission of HIV from mother to child. Lancet 1987;ii:400.
22. Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, Jimenez E, O'Neill E, Bazin B, Delfraissy JF, Culnane M, Coombs R, Elkins M, Moye J, Stratton P, Balsley J, and The Pediatric AIDS Clinical Trial Group Protocol 076 Study Group: Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-1180.
23. Dickover RE, Garratty EM, Herman SA, Sim MS, Plaeger S, Boyer PJ, Keller M, Deveikis A, Steihm ER, and Bryson Y: Identifications of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: Effect of maternal zidovudine treatment on viral load. J Am Med Assoc 1996;278:566-605.
24. Sperling RS, Shapiro DE, Coombs RW, Todd JA, Herman SA, Mc-Sherry GD, O'Sullivan MJ, Van Dyke RB, Jimenez E, Rouzioux C, Flynn PM, Sullivan JL, for the Pediatric AIDS Clinical Trials Group Protocol 076 Study Group: Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996;335: 1621-1629.
25. Rouzioux C, Costagliola D, Burgard M, Blanche S, Mayaux MJ, Griscelli C, Valleron AJ, and the HIV Infection in Newborns French Collaborative Study Group: Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. Am J Epidemiol 1995;142:1 330-1337.
26. Blanche S, Mayaux MJ, Rouzioux C, Teglas JP, Firtion G, Monpoux F, Ciraru-Vigneron N, Meier F, Tricoire J, Courpotin C, Vilmer E, Griscelli C, Delfraissy JF, and the French Pediatric HIV Infection Study Group: Relation of the course of HIV infection in children to the severity of the disease in their mothers at delivery. N Engl J Med 1994;330:308-312.
27. Mayaux MJ, Burgard M, Teglas JP, Cottalorda J, Krivine A, Simon F, Puel J, Tamalet C, Dormont D, Masquelier B, Doussin A, Rouzioux C, Blanche S, for the French Pediatric HIV Infection Study Group: Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. J Am Med Assoc 1996;275: 606-610.
28. Mayaux MJ, Blanche S, Rouzioux C, Le Chenadec J, Chambrin V, Firtion G, Allemon MC, Vilmer E, Ciraru-Vigneron N, Tricoire J, Guillot F, Courpotin C, and the French Pediatric HIV Infection Study Group: Maternal factors associated with perinatal HIV-1 transmission: The French cohort study: 7 years of follow-up observation. J Acquir Immune Defic Syndr 1995;8:188-194.
29. Wolinsky SM, Wike CM, Korber BTM, Hutto C, Parks WP, Rosenblum LL, Kuntsman KJ, Furtado MR, and Munoz LL: Selective transmission of human immunodeficiency virus type-1 variants from mother to infants. Science 1992;255:1134-1137.
30. Scarlatti G, Leitner T, Hapi E, Wahlberg J, Marchisi P, Clerici-Schoeller AA, Wigzell H, Fenyö EM, Albert J, Uhlen M, and Rossi P: Comparison of variable region 3 sequences of human immunodeficiency virus type 1 from infected children with RNA and DNA sequences of virus population of their mothers. Proc Natl Acad Sci USA 1993;90:1721-1725.
31. Blanche S, Rouzioux C, Guihard-Moscato ML, Véber F, Mayaux MJ, Jacomet C, Tricoire J, Deville A, Vial M, Firtion G, de Crépy A, Douard D, Robin M, Courpotin C, Ciraru-Vigneron N, Le Deist F, Griscelli C, and the French Collaborative Group: A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. N Engl J Med 1989;320:1643-1648.
32. Loussert-Ajaka I, Ly TD, Chaix ML, Ingrand D, Saragosti S, Couroucé AM, Brun-Vézinet F, and Simon F: HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994;343:1393-1394.
33. Burgard M, Mayaux MJ, Blanche S, Ferroni A, Guihard-Moscato ML, Allemon MC, Ciraru-Vigneron N, Firtion G, Floch C, Guillot F, Lachassine E, Vial M, Griscelli C, and Rouzioux C: The use of viral culture and p24 antigen testing to diagnose human immunodeficiency virus infection in neonates. N Engl J Med 1992;327:1192-1197.
34. Felsenstein J: PHYLIP (Phylogeny Interference Package), version 3.5c. Berkeley University Herbarium, University of California, Berkeley, 1993.
35. Nei M and Gojobori T: Simple methods for estimating the number of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 1986;3:418-426.
36. Kusumi K, Conway B, Cunningham S, Berson A, Evans C, Iversen AKN, Colvin D, Gallo MV, Coutre S, Shpaer EG, Faulkner DV, DeRonde A, Volkman S, Williams C, Hirsch MS, and Mullins JI: Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro. J Virol 1992;66: 875-885.
37. Learn GH, Korber BTM, Foley B, Hahn BH, Wolinsky SM, and Mullins JI: Maintaining the integrity of human immunodeficiency virus sequence databases. J Virol 1996;70:5720-5730.
38. Lee WR, Syu W, Du B, Matsuda M, Tan S, Wolf A, Essex M, and Lee T: Non-random distribution of gp120 N-linked glycosylation sites important for infectivity of human immunodeficiency viruses type 1. Proc Natl Acad Sci USA 1992;89:2213-2217.
39. Li Y, Luo L, Rasool N, and Kang Y: Glycosylation is necessary for the correct folding of human immunodeficiency virus gp120 in CD4 binding. J Virol 1993;67:584-588.
40. Benjouad A, Gluckman JC, Rochat H, Montagnier L, and Bahraoui E: Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160. J Virol 1992;66:2473-2483.
41. Ahmad N, Baroudy BM, Baker RC, and Chappey C: Genetic analysis of human immunodeficiency virus type 1 envelope V3 region isolates from mothers and infants after perinatal transmission. J Virol 1995;69:1001-1012.
42. Wike CM, Korber BTM, Daniels MR, Hutto C, Munoz J, Furtado M, Parks W, Saah A, Bulterys M, Kurawige JB, and Wolinsky SM: HIV-1 sequence variation between isolates from mother-infant transmission pairs. AIDS Res Hum Retroviruses 1992;8:1297-1300.
43. Lamers SL, Sleasman JW, She JX, Barrie KA, Pomeroy SM, Barrett DJ, and Goodenow MM: Independant variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo. J Virol 1993; 67:3951-3960.
44. Lamers SL, Sleasman JW, She JX, Barrie KA, Pomeroy SM, Barrett DJ, and Goodenow MM: Persistence of multiple maternal genotypes of human immunodeficiency virus type 1 in infants by vertical transmission. J Clin Invest 1994;93:380-390.
45. Cichutek K, Merget H, Norley S, Linde R, Kreuz W, Gahr M, and Kurth R: Development of quasispecies of human immunodeficiency virus type 1 in vivo. Proc Natl Acad Sci USA 1992;89: 7365-7369.
46. Pang S, Shlesinger Y, Darr ES, Moudgh T, and Ho DD: Rapid generation of sequence variation during primary HIV-1 infection. AIDS 1992;6:453-460.
47. Zhang J, MacKenzie LQ, Cleland A, Holms EC, Leigh Brown AJ, and Simmonds P: Selection for specific sequences in the external envelope protein of human immunodeficiency virus type I upon primary infection. J Virol 1993;67:3345-3356.
48. Zhu T, Mo H, Wang N, Nam DS, Cao Y, Koup RA, and Ho DD: Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 1993;261:1179-1181.
49. Mulder-Kampinga GA, Kuiken C, Dekker J, Scherpbier JH, Boer K, and Goudsmit J: Genomic human immunodeficiency virus type 1 RNA variation in mother and child following intrauterine virus transmission. J Gen Virol 1993;74:1747-1756.
50. Wolinsky SM, Korber BTM, Neumann AU, Daniels M, Kunstman KJ, Whetsell AJ, Furtado MR, Cao Y, Ho DD, Safrit JT, and Koup RA: Adaptive evolution of human immunodeficiency virus type-1 during the natural course of infection. Science 1996;272:537-542.